Pharmafile Logo

The inescapable rise of patient-centricity

- PMLiVE

The April issue of PME questions the meaning of ‘patient-centricity’ and whether we are achieving it.

Patient-centricity has become a ubiquitous value within the pharmaceutical industry; however, is pharma delivering on its promise to put patients at the heart of everything they do? Dennis O’Brien, Lucid CEO, believes we are making progress but still have a long way to go.

How do we achieve patient-centricity? Dennis believes we must not lose sight of patients. With the evolution of personalised medicine, we must also personalise the value that we deliver to patients. Dennis thinks that technology is the answer. “Tech provides the opportunity to analyse what patients look at on the internet, indicating their values.” However, this is only a starting point. “We’ve got to think like tech providers and think like consumers. If we can do that, we’ll build trusted communities that provide meaningful value. But we’re just not there yet. For some reason we’re scared to connect to patients. We need to get over it.”

Dennis thinks that achieving this requires a fundamental shift in mindset, moving the goal from outcomes to improving someone’s every-day life. “Patient-centricity is a relentless pursuit. The best players in this space will be those who understand that patient insight gives them a continual point of differentiation – and can track, analyse and respond to it quickly to deliver better value to patients.”

Read more about what Dennis and other industry thought leaders have to say on the inescapable rise of patient-centricity here.

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

My Lucid journey from PMW to Head of Medical

Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced...

Listen, learn and lift off

In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the...

Launch excellence

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

Meet The Lucid Group Talent Team

Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 1)

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on...

My Journey into MedComms #LucidLife

I began as a medical writer after almost a decade working in medical publishing as a production editor. Whilst working in publishing, I was exposed to lots of different writing...

International Women’s Day 2022 #BreakTheBias

Today is International Women’s Day. This day is about gender equality, which, to be achieved, must involve the calling out of gender bias, discrimination and stereotyping.Individually, we're all responsible for...